Journal of the American Medical Association study provides further evidence that Multikine can treat unmet need in ~70% of ...

Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs ...

Steve Loutzenhiser — a father of three from St. Peters, Missouri — experienced “stabbing” back pains and an “electrical burst ...

Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells of head and neck tumors—and ...

CEL-SCI (CVM) announced that a third-party study published on March 6 in JAMA Oncology provided data that support Multikine’s use as a ...

Tel Aviv University researchers used CRISPR to cut the SOX2 gene from head and neck cancer cells, eliminating 50% of tumors in mice. The study, published in Advanced Science, highlights CRISPR’s ...

Learn more about how a research team has successfully used CRISPR gene editing in the fight against cancer.

Researchers from the University of Chicago Medicine Comprehensive Cancer Center demonstrated the potential of a novel treatment approach including immunotherapy to treat advanced human papillomavirus ...

Single-cell analysis revealed the molecular triggers that drive stem cells to become cancerous, which may help inform ...

While liquid biopsies can offer significant advantages, there are critical factors to assess the quality of these solutions ...

Head and neck squamous cell carcinomas responded better to a combination of two immunotherapies than to one immunotherapy ...